Despite cutting-edge vaccines and treatments, one of the most effective ways to stay on top of COVID-19 surges relies on a decidedly basic entity: human waste. Biobot, co-founded by Massachusetts Institute of Technology biologist Mariana Matus and urban-studies researcher Newsha Ghaeli, is the first company to analyze human waste—which can provide an early warning of an impending spike in COVID-19 cases—on a commercial basis. Its technology, which can detect pathogens as well as other substances of interest (like opioids), is now in use at more than 700 sewage sites serving more than 100 million people.
A weekly newsletter featuring conversations with the world’s top CEOs, managers, and founders. Join the Leadership Brief.
More Must-Reads from TIME
- Where Trump 2.0 Will Differ From 1.0
- How Elon Musk Became a Kingmaker
- The Power—And Limits—of Peer Support
- The 100 Must-Read Books of 2024
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision